Genmab | GEN - Los Gastos Financieros De La Deuda

Precio De Mercado
1,700.50
Cambio Diario
-10.50 -0.61%
Mensual
0.71%
Anual
25.96%
Q2 Expectativa
1,628.53




Los Gastos Financieros De La Deuda Cambio Fecha
Agios Pharmaceuticals USD 1.39B 85.53M 2025-09
Amarin USD 3K 5K 2024-12
Amgen USD 653M 32M 2025-12
argenx SE USD 828K 165K 2025-12
AstraZeneca USD 484M 181M 2025-12
Bayer EUR 675M 87M 2025-12
BioMarin Pharmaceutical USD 2.78M 199K 2025-12
Demant DKK 398M 37M 2025-12
Exelixis USD 23.4M 3.9M 2023-09
Fresenius Medical Care EUR 85M 8.1M 2025-12
Galapagos EUR 1.72M 940K 2025-09
Genmab DKK 10M 27M 2025-12
GlaxoSmithKline GBP 188M 21M 2025-12
GN Store Nord DKK 296M 42M 2025-12
GRIFOLS EUR 141.43M 61.28M 2025-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Insmed USD 20.6M 217K 2025-12
Lonza CHF 84M 14M 2025-06
Merck EUR 121M 5M 2025-12
Novartis USD 304M 23M 2025-12
Regeneron Pharmaceuticals USD 12.2M 7.1M 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 178M 203M 2026-03
UCB EUR 49M 29M 2025-12